Arthritis & Rheumatology · 2023 · 17 citations · 33 references
Life SciencesImmunologyMolecular BiologyAutoimmunityImmunopathologyInflammationB Cell BiologyB Cell DevelopmentB-cell ResponsesHumoral ImmunityLymphocyte DevelopmentSystemic Lupus ErythematosusB Cell - Mediated AutoimmunityB Cell DysfunctionB Cell Repertoire FormationB-cell DisordersB-cell Repertoire AnalysisBone Marrow - Derived CellsEarly B Cell DevelopmentSystemic Lupus Erythematosus Associations
Objective The peripheral B cell compartment is heavily disturbed in systemic lupus erythematosus (SLE), but whether B cells develop aberrantly in the bone marrow (BM) is largely unknown. Methods We performed single‐cell RNA/B cell receptor (BCR) sequencing and immune profiling of BM B cells and classified patients with SLE into two groups: early B cell (Pro‐B and Pre‐B) normal (EB nor ) and EB defective/low (EB lo ) groups. Results The SLE‐EB lo group exhibited more severe disease activity and proinflammatory status, overaction of type I interferon signaling and metabolic pathways within the B cell compartment, and aberrant BCR repertoires compared with the SLE‐EB nor group. Moreover, in one patient with SLE who was initially classified in the SLE‐EB lo group, early B cell deficiency and associated abnormalities were largely rectified in a second BM sample at the remission phase. Conclusion In summary, this study suggests that early B cell loss in BM defines a unique pathological state in a subset of patients with SLE that may play an active role in the dysregulated autoimmune responses.
33
SCENIC: single-cell regulatory network inference and clustering
Sara Aibar, Carmen Bravo González‐Blas, Thomas Moerman et al. · Nature Methods · 2017 · 6.9K citations · Full text
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F. Morand, Richard Furie, Yoshiya Tanaka et al. · New England Journal of Medicine · 2019 · 1.3K citations · Full text